Startups
LoQus23

LoQus23 is a small molecule drugs developer for Huntington's disease founded in 2019 by David Reynolds.

GET THE TOP 10 COMPANIES OF THE WEEK IN YOUR EMAIL, EVERY TUESDAY.

OR DOWNLOAD OUR DATABASE OF 23,000 COMPANIES →

Summary

Seedtable Score

Score icon 75

Locations

Last Stage Round

Industry

Total Funding
$43.0M
Full Company Profile